The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19
{{output}}
COVID-19 disproportionately affects older people, with likelihood of severe complications and death mirroring that of other age-associated diseases. Inhibition of the mechanistic target of rapamycin complex 1 (mTORC1) has been shown to delay or reverse many ag... ...
